Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

1.3K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.3K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

3.5K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.5K
Depression: Overview01:18

Depression: Overview

634
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
634
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

331
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
331
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

666
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
666
G-protein Coupled Receptors01:21

G-protein Coupled Receptors

130.5K
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
130.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glioblastoma pathophysiology: roles of aging driven changes in STAT3 interactions with NF-κB dimer components in the modulation of the mitochondrial melatonergic pathway and night-time inflammation resolution.

Exploration of targeted anti-tumor therapy·2026
Same author

Autism Pathoetiology and Pathophysiology: Roles of STAT3 and NF-κB Dimer Interactions in Regulating the Mitochondrial Melatonergic Pathway in Placental, CNS, and Systemic Cells.

Frontiers in bioscience (Landmark edition)·2026
Same author

Cannabinol Interactions With the Melatonergic Pathway.

Basic & clinical pharmacology & toxicology·2025
Same author

Ten "simple" rules for non-Indigenous researchers engaging Indigenous communities in Arctic research.

PLoS computational biology·2024
Same author

Exposure to Plasticiser DEHP Affects Eggs Spawned by Blue Mussels: A Possible Risk to Fertilisation?

Toxics·2024
Same author

Anterior cervical discectomy and fusion versus cervical disc arthroplasty: an epidemiological review of 433,660 surgical patients from 2011 to 2021.

The spine journal : official journal of the North American Spine Society·2024

Related Experiment Video

Updated: Dec 12, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

415

Role of Opioidergic System in Regulating Depression Pathophysiology.

George Anderson1, Michael Maes2

  • 1CRC Scotland & London, Eccleston Square, London, United Kingdom.

Current Pharmaceutical Design
|August 10, 2020
PubMed
Summary

The endogenous opioidergic system plays a key role in major depressive disorder (MDD) pathophysiology. Understanding its interactions offers new therapeutic targets for MDD treatment.

Keywords:
DepressionLPSamygdalaceramidecircadian rhythmendogenous opioidsgut dysbiosisinflammationmelatoninmitochondria

More Related Videos

Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.9K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

740

Related Experiment Videos

Last Updated: Dec 12, 2025

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

415
Animal Models of Depression - Chronic Despair Model CDM
05:47

Animal Models of Depression - Chronic Despair Model CDM

Published on: September 23, 2021

7.9K
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
07:58

Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression

Published on: February 24, 2023

740

Area of Science:

  • Neuroscience
  • Psychiatry
  • Molecular Biology

Background:

  • Major Depressive Disorder (MDD) requires better understanding of its biological basis for targeted treatments.
  • Emerging evidence highlights the involvement of the endogenous opioidergic system in MDD.
  • This review explores the role of the endogenous opioidergic system in MDD pathophysiology and its heterogeneity.

Purpose of the Study:

  • To review the roles and physiological interactions of the endogenous opioidergic system in MDD.
  • To explore the connection between the endogenous opioidergic system and MDD pathophysiology.
  • To identify the endogenous opioidergic system as a potential therapeutic target for MDD.

Main Methods:

  • Literature review of articles on MDD pathophysiology.
  • Literature review of articles on the endogenous opioidergic system.
  • Literature review of articles on mitochondrial function.

Main Results:

  • The endogenous opioidergic system is linked to MDD pathophysiology, affecting gut microbiome, permeability, circadian rhythms, and brain function.
  • A reduced μ-/κ-opioid receptor ratio is a key factor in mood changes in MDD.
  • These effects impact neurons, glia, and immune cells.

Conclusions:

  • The endogenous opioidergic system is integral to MDD pathophysiology.
  • This system presents a viable target for developing novel MDD treatments.
  • It serves as a focal point for integrating a broader understanding of MDD pathophysiology.